Skip to Content Skip to Navigation
27th August 2022 Parkinson’s

Trial shines light on Parkinson's with fluorinated dopamine


Story courtesy of ABC News


More than 200 South Australians have taken part in a cutting-edge trial set to improve the diagnosis of Parkinson’s.

The SA-first trial (using one of only two high-tech cyclotron machines nationally) involves injecting people with fluorinated dopamine (F-Dopa) which then highlights the dopamine in their brain during a scan.

A biobank can then be built to see how this presents differently in people with and without Parkinson’s – improving future diagnosis and treatment.

The Hospital Research Foundation Group is proud to be providing a $300,000 grant for the trial, which involves a collaboration between our Parkinson’s charity, SAHMRI and Dr Jones & Partners Medical Imaging.